Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium.

Donnini, Sandra; Solito, Raffaella; Giachetti, Antonio; Granger, Harris J; Ziche, Marina; Morbidelli, Lucia

Donnini, Sandra; Solito, Raffaella; Giachetti, Antonio; Granger, Harris J; Ziche, Marina; Morbidelli, Lucia.

Affiliation

Donnini S; Pharmacology Section, Department of Molecular Biology, Via A. Moro 2, 53100 Siena, Italy.

J Pharmacol Exp Ther ; 319(2): 515-22, 2006 Nov.

Article in En | MEDLINE | ID: mdl-16868034

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/pharmacology; Coronary Vessels/drug effects; Endothelial Cells/drug effects; Fibroblast Growth Factor 2/physiology; Neovascularization, Physiologic/drug effects; Animals; Captopril/analogs & derivatives; Captopril/pharmacology; Cells, Cultured; Endothelial Cells/physiology; Nitric Oxide Synthase Type III/physiology; Receptor, Bradykinin B1/physiology; Receptor, Fibroblast Growth Factor, Type 1/physiology; Swine

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Fibroblast Growth Factor 2 / Neovascularization, Physiologic / Coronary Vessels / Endothelial Cells Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 2006 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links